Literature DB >> 9276086

Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities.

C J Rosen1, H P Dimai, D Vereault, L R Donahue, W G Beamer, J Farley, S Linkhart, T Linkhart, S Mohan, D J Baylink.   

Abstract

Recent work has demonstrated differences in femoral bone mineral density between two common inbred strains of mice, C3H/HeJ (C3H) and C57BL/6J (B6), across a wide age range. To investigate one possible mechanism that could affect acquisition and maintenance of bone mass in mice, we studied circulatory and skeletal insulin-like growth factor-I (IGF-I) and femoral bone mineral density (F-BMD) by pQCT in C3H and B6 progenitor strains, as well as serum IGF-I obtained from matings between these two strains and mice bred from subsequent F1 intercrosses (F2). Serum IGF-I measured by radioimmunoassay was more than 35% higher in virgin progenitor C3H than virgin B6 at 1, 4, 8, and 10 months of age, and in 8-month-old C3H compared with B6 retired breeders (p < 0.001). In the progenitors, there was also a strong correlation between serum IGF-I and serum alkaline phosphatase (r = 0.51, p = 0.001). In the 4 month F1 females IGF-I levels and F-BMD were intermediate between C3H and B6 progenitors. In contrast, groups of F2 mice with the highest or lowest BMD also had the highest or lowest serum IGF-I (p = 0.0001). IGF-I accounted for > 35% of the variance in F-BMD among the F2 mice. Conditioned media from newborn C3H calvarial cultures had higher concentrations of IGF-I than media from B6 cultures, and cell layer extracts from C3H calvariae exhibited greater alkaline phosphatase activity than cultures from B6 calvarial cells (p < 0.0001). The skeletal content of IGF-I in C3H tibiae, femorae, and calvariae (6-14 weeks of age) was also significantly higher than IGF-I content in the same bones of the B6 mice (p < 0.05). These data suggest that a possible mechanism for the difference in acquisition and maintenance of bone mass between these two inbred strains is related to systemic and skeletal IGF-I synthesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276086     DOI: 10.1016/s8756-3282(97)00143-9

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  31 in total

1.  Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms.

Authors:  Subburaman Mohan; Charmaine Richman; Rongqing Guo; Yousef Amaar; Leah Rea Donahue; Jon Wergedal; David J Baylink
Journal:  Endocrinology       Date:  2003-03       Impact factor: 4.736

2.  Insulin-like growth factor-1 increases bone calcium accumulation only during rapid growth in female rats.

Authors:  Qinmin Zhang; Meryl E Wastney; Clifford J Rosen; Wesley G Beamer; Connie M Weaver
Journal:  J Nutr       Date:  2011-09-28       Impact factor: 4.798

3.  Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions.

Authors:  Shoshana Yakar; Ernesto Canalis; Hui Sun; Wilson Mejia; Yuki Kawashima; Philip Nasser; Hayden-William Courtland; Valerie Williams; Mary Bouxsein; Clifford Rosen; Karl J Jepsen
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

4.  IGF-1 and survival in ESRD.

Authors:  Ting Jia; Thiane Gama Axelsson; Olof Heimbürger; Peter Bárány; Bengt Lindholm; Peter Stenvinkel; Abdul Rashid Qureshi
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

5.  Bioenergetics during calvarial osteoblast differentiation reflect strain differences in bone mass.

Authors:  Anyonya R Guntur; Phuong T Le; Charles R Farber; Clifford J Rosen
Journal:  Endocrinology       Date:  2014-01-17       Impact factor: 4.736

6.  Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover.

Authors:  N Ogata; D Chikazu; N Kubota; Y Terauchi; K Tobe; Y Azuma; T Ohta; T Kadowaki; K Nakamura; H Kawaguchi
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

7.  Serum sclerostin decreases following 12months of resistance- or jump-training in men with low bone mass.

Authors:  Pamela S Hinton; Peggy Nigh; John Thyfault
Journal:  Bone       Date:  2016-10-12       Impact factor: 4.398

8.  Circulating levels of IGF-1 directly regulate bone growth and density.

Authors:  Shoshana Yakar; Clifford J Rosen; Wesley G Beamer; Cheryl L Ackert-Bicknell; Yiping Wu; Jun-Li Liu; Guck T Ooi; Jennifer Setser; Jan Frystyk; Yves R Boisclair; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  Quantitative ontogeny of murine insulin-like growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acid-labile subunit.

Authors:  David L Hwang; Phillip D K Lee; Pinchas Cohen
Journal:  Growth Horm IGF Res       Date:  2007-08-23       Impact factor: 2.372

10.  Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions.

Authors:  W Kalus; M Zweckstetter; C Renner; Y Sanchez; J Georgescu; M Grol; D Demuth; R Schumacher; C Dony; K Lang; T A Holak
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.